Design Therapeutics Stock Analysis

Design Stock Analysis Notes

About 36.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.89. Some equities with similar Price to Book (P/B) outperform the market in the long run. Design Therapeutics recorded a loss per share of 0.87. The entity had not issued any dividends in recent years. Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California. Design Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 51 people. To learn more about Design Therapeutics call Joo MD at 858 293 4900 or check out https://www.designtx.com.

Design Therapeutics Investment Alerts

Design Therapeutics Upcoming and Recent Events

Design Largest EPS Surprises

View All Earnings Estimates

Design Therapeutics Environmental, Social, and Governance (ESG) Scores

Design Therapeutics Thematic Classifications

Design Stock Institutional Investors

Note, although Design Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Design Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 231.01 M.

Design Profitablity

Management Efficiency

Design Therapeutics has return on total asset (ROA) of (0.1354) % which means that it has lost $0.1354 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1778) %, meaning that it created substantial loss on money invested by shareholders. Design Therapeutics' management efficiency ratios could be used to measure how well Design Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 16th of February 2025, Return On Tangible Assets is likely to drop to -0.22. In addition to that, Return On Capital Employed is likely to grow to -0.31. At this time, Design Therapeutics' Other Current Assets are very stable compared to the past year. As of the 16th of February 2025, Asset Turnover is likely to grow to 0.000007, while Total Assets are likely to drop about 232.7 M.

Technical Drivers

As of the 16th of February 2025, Design Therapeutics shows the Mean Deviation of 4.52, standard deviation of 6.19, and Variance of 38.27. Design Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Design Therapeutics Price Movement Analysis

Design Therapeutics Insider Trading Activities

Design Therapeutics Outstanding Bonds

Design Therapeutics Predictive Daily Indicators

Design Therapeutics Corporate Filings

Design Therapeutics Forecast Models

Design Therapeutics' time-series forecasting models are one of many Design Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Design Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Design Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Design shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Design Therapeutics. By using and applying Design Stock analysis, traders can create a robust methodology for identifying Design entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Design analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Design analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Design Therapeutics stock analysis indicators help investors evaluate how Design Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Design Therapeutics shares will generate the highest return on investment. By understating and applying Design Therapeutics stock analysis, traders can identify Design Therapeutics position entry and exit signals to maximize returns.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Design Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Design Stock, please use our How to Invest in Design Therapeutics guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Design Therapeutics. If investors know Design will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Design Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Design Therapeutics is measured differently than its book value, which is the value of Design that is recorded on the company's balance sheet. Investors also form their own opinion of Design Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Design Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Design Therapeutics' market value can be influenced by many factors that don't directly affect Design Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Design Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Design Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Design Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.